Published in Curr Opin Allergy Clin Immunol on October 01, 2012
Role of vascular networks in extending glucose sensor function: Impact of angiogenesis and lymphangiogenesis on continuous glucose monitoring in vivo. J Biomed Mater Res A (2013) 0.81
Corneal lymphangiogenesis in herpetic stromal keratitis. Surv Ophthalmol (2014) 0.81
Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization. Br J Pharmacol (2015) 0.75
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest (2005) 3.77
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med (2004) 2.64
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci (2007) 2.05
Epithelial-Mesenchymal Transition (EMT)-Related Cytokines in the Aqueous Humor of Phakic and Pseudophakic Fuchs' Dystrophy Eyes. Invest Ophthalmol Vis Sci (2015) 2.04
Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol (2009) 1.97
Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci (2003) 1.93
Optimizing descemet membrane endothelial keratoplasty using intraoperative optical coherence tomography. JAMA Ophthalmol (2013) 1.82
Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol (2012) 1.68
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology (2009) 1.67
Pressure-induced interlamellar stromal keratitis after laser in situ keratomileusis. Cornea (2011) 1.66
Histologic analysis of descemet stripping in posterior lamellar keratoplasty. Arch Ophthalmol (2008) 1.52
Reproducibility of graft preparations in Descemet's membrane endothelial keratoplasty. Ophthalmology (2013) 1.51
Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology (2010) 1.46
Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol (2006) 1.41
A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty. Cornea (2011) 1.40
The Pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology (2005) 1.36
Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol (2002) 1.33
Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology (2010) 1.29
Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol (2007) 1.29
Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol (2008) 1.27
Descemet membrane endothelial keratoplasty: the taming of the shrew. JAMA Ophthalmol (2013) 1.24
Descemet stripping endothelial keratoplasty--rapid recovery of visual acuity. Dtsch Arztebl Int (2013) 1.24
Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res (2013) 1.22
Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci (2005) 1.22
Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg (2009) 1.21
Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology (2010) 1.21
Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol (2007) 1.20
Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2009) 1.18
Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. Am J Ophthalmol (2007) 1.16
Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 1.15
Corneal higher-order aberrations after Descemet's membrane endothelial keratoplasty. Ophthalmology (2011) 1.14
Ciliary body lymphangiogenesis. Ophthalmology (2013) 1.11
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med (2011) 1.10
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea (2012) 1.10
Optimising deep anterior lamellar keratoplasty (DALK) using intraoperative online optical coherence tomography (iOCT). Br J Ophthalmol (2014) 1.09
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res (2004) 1.08
Pentacam-based big bubble deep anterior lamellar keratoplasty in patients with keratoconus. Cornea (2012) 1.07
Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients. Am J Ophthalmol (2011) 1.07
Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci (2009) 1.04
Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci (2009) 1.02
Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody). Cornea (2008) 1.02
Split cornea transplantation: relationship between storage time of split donor tissue and outcome. Ophthalmology (2013) 1.01
Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol (2011) 1.00
Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman. Lymphat Res Biol (2008) 1.00
The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages. Invest Ophthalmol Vis Sci (2008) 0.98
Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea (2011) 0.98
Adhesion structures of amniotic membranes integrated into human corneas. Invest Ophthalmol Vis Sci (2006) 0.97
Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs. Cornea (2012) 0.96
Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels. PLoS One (2011) 0.96
Descemet membrane endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation: advanced triple procedure. Am J Ophthalmol (2012) 0.96
Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva. Ophthalmology (2011) 0.96
Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers. Graefes Arch Clin Exp Ophthalmol (2014) 0.95
Donor tissue culture conditions and outcome after descemet membrane endothelial keratoplasty. Am J Ophthalmol (2011) 0.94
Genetic heterogeneity of lymphangiogenesis in different mouse strains. Am J Pathol (2010) 0.93
A new surgical triple procedure in pseudoexfoliation glaucoma using cataract surgery, Trabectome, and trabecular aspiration. Graefes Arch Clin Exp Ophthalmol (2014) 0.93
Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology (2009) 0.92
Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J Immunol (2010) 0.92
Intraoperative Optical Coherence Tomography Enables Noncontact Imaging During Canaloplasty. J Glaucoma (2016) 0.92
Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci (2008) 0.91
Microbubble incision as a new rescue technique for big-bubble deep anterior lamellar keratoplasty with failed bubble formation. Cornea (2013) 0.91
Rebound, applanation, and dynamic contour tonometry in pathologic corneas. Cornea (2013) 0.91
Histopathological changes after deep anterior lamellar keratoplasty using the 'big-bubble technique'. Acta Ophthalmol (2011) 0.89
Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1. Blood (2012) 0.89
Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci (2011) 0.88
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival. J Immunol (2013) 0.88
A method to confirm correct orientation of descemet membrane during descemet membrane endothelial keratoplasty. Am J Ophthalmol (2010) 0.87
The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages. Invest Ophthalmol Vis Sci (2012) 0.86
Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuropathy (CIDP). J Peripher Nerv Syst (2014) 0.85
Myofibroblast metaplasia after descemet membrane endothelial keratoplasty. Am J Ophthalmol (2011) 0.85
Corneal graft alterations after Descemet stripping: implications for split cornea transplantation. JAMA Ophthalmol (2013) 0.84
Recurrent interface abscess secondary to Acanthamoeba keratitis treated by deep anterior lamellar keratoplasty. Int J Ophthalmol (2012) 0.84
Enrichment of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1)-positive macrophages around blood vessels in the normal human sclera. Invest Ophthalmol Vis Sci (2014) 0.84
Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye. J Ocul Pharmacol Ther (2012) 0.84
"PISK-itis" or "PISK-opathy"? Cornea (2012) 0.84
Corneal nerve alterations after Descemet membrane endothelial keratoplasty: an in vivo confocal microscopy study. Cornea (2014) 0.84
Spectrum of Uveitis in A German Tertiary Center: Review of 474 Consecutive Patients. Ocul Immunol Inflamm (2015) 0.84
Characterization of the cleavage plane in DESCemet's membrane endothelial keratoplasty. Ophthalmology (2011) 0.82
Atopic dermatitis as a risk factor for graft rejection following normal-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol (2008) 0.82
The association between corneal neovascularization and visual acuity: a systematic review. Acta Ophthalmol (2011) 0.82
Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis. Acta Ophthalmol (2012) 0.82
Lymphatic vessels in the development of tissue and organ rejection. Adv Anat Embryol Cell Biol (2014) 0.81
Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy. Invest Ophthalmol Vis Sci (2014) 0.81
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. 2004. Ocul Immunol Inflamm (2007) 0.81
Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease. Graefes Arch Clin Exp Ophthalmol (2012) 0.81
HIV and hepatitis B/C infections in patients donating blood for use as autologous serum eye drops. Br J Ophthalmol (2007) 0.81
Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration. Invest Ophthalmol Vis Sci (2012) 0.80
Small-Fiber Neuropathy Is Associated With Corneal Nerve and Dendritic Cell Alterations: An In Vivo Confocal Microscopy Study. Cornea (2015) 0.80
Immediate Postoperative Intraocular Pressure Changes After Anterior Chamber Air Fill in Descemet Membrane Endothelial Keratoplasty. Cornea (2016) 0.80